There's a lot to be optimistic about in the Services sector as 2 analysts just weighed in on Starbucks (SBUX – Research Report) and Evolent Health (EVH – Research Report) with bullish sentiments. Starbucks (SBUX) BTIG analyst Peter Saleh reiterated a Buy rating on Starbucks yesterday and set a price target of $110.00. The company's shares closed last Wednesday at $81.64, close to its 52-week low of $73.38. According to TipRanks.com, Saleh is a 5-star analyst with an average return of > Evolent Health (EVH) In a report released yesterday, David Larsen from BTIG maintained a Buy rating on Evolent Health, with a price target of $45.00.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-services-companies-starbucks-sbux-and-evolent-health-evh?utm_source=advfn.com&utm_medium=referral
Starbucks (NASDAQ:SBUX)
Historical Stock Chart
Von Mai 2022 bis Jun 2022 Click Here for more Starbucks Charts.
Starbucks (NASDAQ:SBUX)
Historical Stock Chart
Von Jun 2021 bis Jun 2022 Click Here for more Starbucks Charts.